MENU
+Compare
ONVO
Stock ticker: NASDAQ
AS OF
Mar 10, 04:59 PM (EDT)
Price
$0.41
Change
-$0.04 (-8.89%)
Capitalization
7.86M

ONVO Organovo Holdings Forecast, Technical & Fundamental Analysis

Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data... Show more

Industry: #Biotechnology
ONVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ONVO with price predictions
Mar 04, 2025

ONVO's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ONVO turned positive on February 10, 2025. Looking at past instances where ONVO's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Momentum Indicator moved above the 0 level on February 12, 2025. You may want to consider a long position or call options on ONVO as a result. In of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

ONVO moved above its 50-day moving average on February 25, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ONVO crossed bullishly above the 50-day moving average on February 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONVO advanced for three days, in of 223 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for ONVO moved out of overbought territory on February 26, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ONVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ONVO broke above its upper Bollinger Band on February 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for ONVO entered a downward trend on February 13, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ONVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.598) is normal, around the industry mean (11.742). P/E Ratio (0.000) is within average values for comparable stocks, (66.249). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.790). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (56.180) is also within normal values, averaging (229.516).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ONVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ONVO is expected to report earnings to rise 78.57% to -25 cents per share on February 28

Organovo Holdings ONVO Stock Earnings Reports
Q4'24
Est.
$-0.25
Q3'24
Beat
by $0.12
Q2'24
Est.
$-0.23
Q1'24
Beat
by $0.03
Q4'23
Est.
$-0.36
The last earnings report on November 07 showed earnings per share of -14 cents, beating the estimate of -25 cents. With 334.54K shares outstanding, the current market capitalization sits at 7.86M.
A.I. Advisor
published General Information

General Information

a company which engages in developing and commercializing functional human tissues

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
11555 Sorrento Valley road
Phone
+1 858 224-1000
Employees
24
Web
https://www.organovo.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X87222.1950001156.515600
+1.34%
Bitcoin cryptocurrency
GME24.30-0.10
-0.41%
GameStop Corp
AAPL235.93-2.10
-0.88%
Apple
SPY576.86-6.91
-1.18%
SPDR® S&P 500® ETF Trust
TSLA272.04-12.61
-4.43%
Tesla

ONVO and Stocks

Correlation & Price change

A.I.dvisor tells us that ONVO and LVTX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ONVO and LVTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONVO
1D Price
Change %
ONVO100%
-13.30%
LVTX - ONVO
28%
Poorly correlated
+0.79%
KRRO - ONVO
26%
Poorly correlated
-5.10%
BEAM - ONVO
25%
Poorly correlated
+5.34%
HLVX - ONVO
24%
Poorly correlated
+1.71%
MLTX - ONVO
24%
Poorly correlated
+1.49%
More